FHTX
Foghorn Therapeutics Inc.
NASDAQ · Healthcare · Biotechnology · US
$2.21
+3.52%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 10.88x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- -1.62x
- Price / sales
- 3.56x
- Price / cash flow
- -1.54x
Enterprise value
- Enterprise value
- $6.5M
- EV / sales
- 0.18x
- EV / EBITDA
- -0.10x
- EV / EBIT
- -0.09x
- Market cap
- $130.9M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026